<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20120729010439N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-20</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of a Combined Proprioceptive Exercise and Myofascial Release Protocol on Muscle Strength and Endurance</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the Effectiveness of an Eight-Week Combined Protocol of Proprioceptive Exercises and Myofascial Release on Improving Muscle Strength and Endurance in Women with Chronic Nonspecific Low Back Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-12-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/94904</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be allocated to the intervention groups using matched-triplet block randomization. Initially, participants will be matched into sets of three based on similar baseline pain scores measured using the Visual Analog Scale (VAS). Subsequently, within each set, participants will be randomly assigned in a 1:1:1 allocation ratio to one of three groups: proprioceptive exercises, myofascial release, or the combined intervention protocol. The random allocation sequence will be generated by an independent individual who is not involved in participant recruitment or outcome assessment, using Microsoft Excel software. To prevent allocation bias, sequentially numbered, opaque, sealed envelopes will be used. Outcome assessments will be conducted by an independent assessor who will be blinded to the participants' group assignments, Blinding description: Considering the gender of the study participants, all assessments will be conducted at two time points (pre-test and post-test) by a trained assessor who is independent of the principal investigator. Prior to the commencement of the study, the assessor will receive appropriate training on the administration of the assessment procedures and the recording of results. The pre-test assessments will be performed before participants are allocated to the study groups. Subsequently, participants will be assigned to the study groups using a matching procedure based on their pain scores. The outcome assessor will remain unaware of participants' group allocation and the intervention procedures throughout the study. Therefore, outcome assessments will be conducted under blinded conditions.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic Nonspecific Low Back Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: all participants in this group will perform proprioceptive exercises for 8 weeks, with three sessions per week. Weeks 1–2: The exercises will include transversus abdominis activation in the supine position (10 repetitions, holding each contraction for 10 seconds); transversus abdominis and multifidus activation in the prone position (10 repetitions, holding each contraction for 10 seconds); transversus abdominis and multifidus activation in the quadruped position (10 repetitions, holding each contraction for 10 seconds); and diaphragmatic activation in the supine and quadruped positions (10 repetitions, 3 sets). Weeks 3–4: The exercises will include glute bridge (10 repetitions, with a 10-second isometric hold); single-leg glute bridge (10 repetitions, with a 10-second isometric hold); transversus abdominis and multifidus co-contraction in the sitting position (10 repetitions, holding each contraction for 10 seconds); and transversus abdominis and multifidus co-contraction in the sitting position with forward bending (10 repetitions, holding each contraction for 10 seconds). Weeks 5–6: The exercises from the first and second phases will be continued, with the addition of bird-dog (10 repetitions, 3 sets, with a 3–5-second isometric hold per repetition); dead bug (10 repetitions, 3 sets, with a 3–5-second isometric hold per repetition); and standing hip flexion with lumbar support (10 repetitions, holding each contraction for 10 seconds). Weeks 7–8: All exercises from the previous phases will be continued, with the addition of side plank (2 sets of 40 seconds); plank (2 sets of 40 seconds); and cat-camel exercise (10 repetitions, 3 sets). Intervention 2: Intervention group: all participants in this group will undergo myofascial release for 8 weeks, with three sessions per week. Weeks 1–2: Cross-hand technique will be performed for 3 repetitions of 90 seconds each, with rest periods consisting of two 30-second intervals. Weeks 3–5: Cross-hand technique will be performed for 4 repetitions of 90 seconds each, with rest periods consisting of two 30-second intervals. Weeks 6–8: Cross-hand technique will be performed for 5 repetitions of 90 seconds each, with rest periods consisting of two 15-second intervals. Intervention 3: Intervention group: all participants in this group will undergo a combined protocol consisting of proprioceptive exercises (identical to those performed by the first group) and myofascial release (identical to that performed by the second group) for 8 weeks, with three sessions per week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Babak Vahdatpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan University of Medical Sciences, Hezar Jerib Street</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3668 5555</telephone>
        <email>Vahdatpour@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Babak Vahdatpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan University of Medical Sciences, Hezar Jerib Street</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3668 5555</telephone>
        <email>Vahdatpour@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women aged 30–50 years with chronic nonspecific low back pain
Low back pain intensity score between 2 and 5 based on the Visual Analog Scale (VAS)
Voluntary informed consent to participate in the study</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Presence of a specific structural cause of low back pain
History of spinal surgery
Diagnosis of a specific neurological disorder</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: all participants in this group will perform proprioceptive exercises for 8 weeks, with three sessions per week. Weeks 1–2: The exercises will include transversus abdominis activation in the supine position (10 repetitions, holding each contraction for 10 seconds); transversus abdominis and multifidus activation in the prone position (10 repetitions, holding each contraction for 10 seconds); transversus abdominis and multifidus activation in the quadruped position (10 repetitions, holding each contraction for 10 seconds); and diaphragmatic activation in the supine and quadruped positions (10 repetitions, 3 sets). Weeks 3–4: The exercises will include glute bridge (10 repetitions, with a 10-second isometric hold); single-leg glute bridge (10 repetitions, with a 10-second isometric hold); transversus abdominis and multifidus co-contraction in the sitting position (10 repetitions, holding each contraction for 10 seconds); and transversus abdominis and multifidus co-contraction in the sitting position with forward bending (10 repetitions, holding each contraction for 10 seconds). Weeks 5–6: The exercises from the first and second phases will be continued, with the addition of bird-dog (10 repetitions, 3 sets, with a 3–5-second isometric hold per repetition); dead bug (10 repetitions, 3 sets, with a 3–5-second isometric hold per repetition); and standing hip flexion with lumbar support (10 repetitions, holding each contraction for 10 seconds). Weeks 7–8: All exercises from the previous phases will be continued, with the addition of side plank (2 sets of 40 seconds); plank (2 sets of 40 seconds); and cat-camel exercise (10 repetitions, 3 sets).</i_keyword>
      <i_keyword>Intervention group: all participants in this group will undergo myofascial release for 8 weeks, with three sessions per week. Weeks 1–2: Cross-hand technique will be performed for 3 repetitions of 90 seconds each, with rest periods consisting of two 30-second intervals. Weeks 3–5: Cross-hand technique will be performed for 4 repetitions of 90 seconds each, with rest periods consisting of two 30-second intervals. Weeks 6–8: Cross-hand technique will be performed for 5 repetitions of 90 seconds each, with rest periods consisting of two 15-second intervals.</i_keyword>
      <i_keyword>Intervention group: all participants in this group will undergo a combined protocol consisting of proprioceptive exercises (identical to those performed by the first group) and myofascial release (identical to that performed by the second group) for 8 weeks, with three sessions per week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Muscle strength. Timepoint: Before and immediately after the intervention. Method of measurement: Digital Handheld Dynamometer.</prim_outcome>
      <prim_outcome>Muscular Endurance. Timepoint: Before and immediately after the intervention. Method of measurement: McGill Trunk Muscle Endurance Tests.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Isfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-11-15</approval_date>
        <contact_name>Research Ethics Committees of School of Medicine - Isfahan University of Medical Sciences</contact_name>
        <contact_address>Isfahan University of Medical Sciences, Hezar Jerib Street Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
